Fulgent Genetics Non-GAAP EPS of $0.14 beats by $0.36, revenue of $84.07M beats by $2.64M
Source: SeekingAlpha
2025-11-07 07:06:48 ET
More on Fulgent Genetics
- Fulgent Genetics: Core Growth Re-Acceleration And Gross Margin Expansion Are On Track (Reiterate Buy)
- Fulgent Genetics Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Fulgent Genetics
- Historical earnings data for Fulgent Genetics
- Financial information for Fulgent Genetics
Read the full article on Seeking Alpha
For further details see:
Fulgent Genetics Non-GAAP EPS of $0.14 beats by $0.36, revenue of $84.07M beats by $2.64M
Fulgent Genetics Inc.
NASDAQ: FLGT
FLGT Trading
-1.44% G/L:
$14.34 Last:
283,822 Volume:
$14.17 Open:
FLGT Latest News
February 12, 2026 07:30:00 am
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
FLGT Stock Data
$726,441,212
20,677,299
5.21%
56
N/A
Medical Diagnostics & Screening
Healthcare
US
El Monte
